{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:54:37Z","timestamp":1776462877463,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.mric.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:49Z","timestamp":1773817189000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular MR in Cardiac Amyloidosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Chi Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Alvarez-Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Barac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcmg.2023.10.010","article-title":"Current and evolving multimodality cardiac imaging in managing transthyretin amyloid cardiomyopathy","volume":"17","author":"Alwan","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.mric.2026.02.002_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.mric.2026.02.002_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014645","article-title":"Optimal echocardiographic parameters to improve the diagnostic yield of Tc-99m-bone avid tracer cardiac scintigraphy for transthyretin cardiac amyloidosis","volume":"15","author":"Cuddy","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.mric.2026.02.002_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.mric.2026.02.002_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.mric.2026.02.002_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102525","article-title":"Cardiac magnetic resonance in the evaluation and management of nonischemic cardiomyopathies","volume":"13","author":"Hosadurg","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2019.08.001","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"25","author":"Dorbala","year":"2019","journal-title":"J Card Fail"},{"issue":"1 Pt 1","key":"10.1016\/j.mric.2026.02.002_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.mric.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1253\/circj.CJ-16-1259","article-title":"Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging","volume":"81","author":"Oda","year":"2017","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cardfail.2024.08.046","article-title":"Cardio-oncology and heart failure: AL amyloidosis for the heart failure clinician: a supplement to the scientific statement from the Heart Failure Society of America","volume":"31","author":"Bloom","year":"2025","journal-title":"J Card Fail"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.mric.2026.02.002_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-imaging characterization of cardiac phenotype in different types of amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.mric.2026.02.002_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13506129.2025.2462541","article-title":"Factors associated with financial toxicity in patients with transthyretin amyloidosis: results from Amyloidosis Research Consortium's treatment affordability patient and caregiver survey","volume":"32","author":"Rebello","year":"2025","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12968-021-00775-8","article-title":"Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance","volume":"23","author":"Giusca","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics","volume":"19","author":"Williams","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.mric.2026.02.002_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00392-023-02348-4","article-title":"Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy","volume":"113","author":"Steen","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.mric.2026.02.002_bib19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"10.1016\/j.mric.2026.02.002_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMc1917321","article-title":"Epidemiologic and survival trends in amyloidosis, 1987-2019","volume":"382","author":"Ravichandran","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mric.2026.02.002_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mric.2026.02.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.04.008","article-title":"Vutrisiran improves survival and reduces cardiovascular events in ATTR amyloid cardiomyopathy: HELIOS-B","author":"Witteles","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mric.2026.02.002_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.5770","article-title":"Clinical ApoA-IV amyloid is associated with fibrillogenic signal sequence","volume":"255","author":"Canetti","year":"2021","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.mric.2026.02.002_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506120600960288","article-title":"Structure, function and amyloidogenic propensity of apolipoprotein A-I","volume":"13","author":"Obici","year":"2006","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.mric.2026.02.002_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.mric.2026.02.002_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/clc.22368","article-title":"Hospital volume and cardiac complications of endomyocardial biopsy: a retrospective cohort study of 9508 adult patients using a nationwide inpatient database in Japan","volume":"38","author":"Isogai","year":"2015","journal-title":"Clin Cardiol"},{"issue":"14","key":"10.1016\/j.mric.2026.02.002_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033478","article-title":"Outcomes in cardiac transthyretin amyloidosis and association with New York Heart Association Class: real-world data","volume":"13","author":"M\u00fcller","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.mric.2026.02.002_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.mric.2026.02.002_bib33","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mric.2026.02.002_bib34","doi-asserted-by":"crossref","first-page":"oead092","DOI":"10.1093\/ehjopen\/oead092","article-title":"Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis","volume":"3","author":"Boretto","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.mric.2026.02.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131892","article-title":"Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: a systematic review and meta-analysis","volume":"403","author":"Cai","year":"2024","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.mric.2026.02.002_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.12324","article-title":"Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging","volume":"277","author":"Barison","year":"2015","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.mric.2026.02.002_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamacardio.2024.2555","article-title":"Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis","volume":"9","author":"Porcari","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac troponin in patients with light chain and transthyretin cardiac amyloidosis: JACC: CardioOncology state-of-the-art review","volume":"6","author":"De Michieli","year":"2024","journal-title":"JACC CardioOncol"},{"issue":"25","key":"10.1016\/j.mric.2026.02.002_bib39","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12968-018-0478-3","article-title":"Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis","volume":"20","author":"Ridouani","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12968-020-00619-x","article-title":"Cardiac T2 mapping: robustness and homogeneity of standardized in-line analysis","volume":"22","author":"Wiesmueller","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diii.2016.08.007","article-title":"Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging","volume":"98","author":"Legou","year":"2017","journal-title":"Diagn Interv Imaging"},{"issue":"8","key":"10.1016\/j.mric.2026.02.002_bib43","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00330-011-2109-3","article-title":"Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis","volume":"21","author":"Wassmuth","year":"2011","journal-title":"Eur Radiol"},{"issue":"14","key":"10.1016\/j.mric.2026.02.002_bib44","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.3390\/jcm11144116","article-title":"Decreased left atrial reservoir strain is associated with adverse outcomes in restrictive cardiomyopathy","volume":"11","author":"Stojanovska","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.mric.2026.02.002_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"14","key":"10.1016\/j.mric.2026.02.002_bib46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.mric.2026.02.002_bib47","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcmg.2023.02.019","article-title":"Tracking multiorgan treatment response in systemic AL-amyloidosis with cardiac magnetic resonance derived extracellular volume mapping","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.mric.2026.02.002_bib48","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping","volume":"8","author":"Ioannou","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.mric.2026.02.002_bib49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bjh.13155","article-title":"Guidelines on the management of AL amyloidosis","volume":"168","author":"Wechalekar","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.mric.2026.02.002_bib50","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jmri.25678","article-title":"Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis","volume":"46","author":"Arani","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"sup1","key":"10.1016\/j.mric.2026.02.002_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13506129.2017.1278689","article-title":"Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis","volume":"24","author":"Chang","year":"2017","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.mric.2026.02.002_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12968-019-0519-6","article-title":"Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy","volume":"21","author":"Gastl","year":"2019","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:10:52Z","timestamp":1776460252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968926000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1064968926000139"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2026.02.002","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular MR in Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}